Universal Vision Biotechnology Co., Ltd. (TPEX:3218)

Market Cap	12.12B
Revenue (ttm)	4.26B
Net Income (ttm)	887.85M
Shares Out	84.73M
EPS (ttm)	10.44
PE Ratio	13.69
Forward PE	9.87
Dividend	7.50 (5.24%)
Ex-Dividend Date	Mar 26, 2025

Volume	149,206
Average Volume	287,567
Open	142.50
Previous Close	142.50
Day's Range	142.50 - 145.50
52-Week Range	138.50 - 244.50
Beta	0.37
RSI	32.62
Earnings Date	Nov 11, 2025

About TPEX:3218

Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical devices, glasses, lens, and vision aid products. It is also involved in leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy services, as well as provides medical and scientific prescription eyeglasses. Further, it offers sunglasses, fashionable and reading glasses, and progressive lenses for presbyopia. Additionally, the company provides contact lenses fo...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1992
• Employees: 401
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 3218

Financial Performance

In 2024, TPEX:3218's revenue was 4.23 billion, an increase of 3.58% compared to the previous year's 4.08 billion. Earnings were 1.06 billion, an increase of 1.88%.